FGF 19 and Bile Acids Increase Following Roux-en-Y Gastric Bypass but Not After Medical Management in Patients with Type 2 Diabetes

Background This study aims to quantify changes in fibroblast growth factor 19 (FGF19) and bile acids (BAs) in patients with uncontrolled type 2 diabetes randomized to Roux-en-Y gastric bypass (RYGB) vs intensive medical management (IMM) and matched for similar reduction in HbA1c after 1 year of trea...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Obesity surgery 2016-05, Vol.26 (5), p.957-965
Hauptverfasser:	Sachdev, Saachi, Wang, Qi, Billington, Charles, Connett, John, Ahmed, Leaque, Inabnet, William, Chua, Streamson, Ikramuddin, Sayeed, Korner, Judith
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Bile Bile Acids and Salts - blood Blood Glucose - metabolism Diabetes Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - surgery Fasting - blood Female Fibroblast Growth Factors - blood Gastric Bypass Gastrointestinal surgery Growth factors Humans Hypoglycemic Agents - therapeutic use Male Medicine Medicine & Public Health Middle Aged Obesity Obesity, Morbid - blood Obesity, Morbid - complications Obesity, Morbid - surgery Original Contributions Postprandial Period Surgery Surgical outcomes Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!